Univercells invests in Jumet for the large-scale production of vaccines

March 19th 2020


Univercells confirmed the acquisition of an industrial site of 15,000 m² in Jumet.  This acquisition reflects the company's commitment to become a long-term supplier of essential vaccines that are currently not widely available on a world scale.  The new site will create local employment and strengthen the positioning of the Walloon and Belgian biotechnology ecosystem.  Please discover the press release here.